KPL Kwality Pharmaceuticals Limite
Healthcare
LTP
3,473.55
CHG · %
-207.4 (-5.63%)
VOL · TODAY
26.86K
PREV CLOSE
3,680.95
Today's range3,459.65 · 3,729.5
3,473.55
52-week range1,561 · 3,949
3,473.55
Loading candles…
Kwality Pharmaceuticals Ltd. is a research-driven company operating in the pharmaceutical industry, focused on the development and manufacturing of finished dosage formulations. The company serves a diverse international market, with operations spanning over 70 countries across multiple regions, including the Middle East, French West Africa, Latin America, and South East Asia (ASEAN). While information on its founding year, key management, and headquarters is not provided, Kwality Pharmaceuticals Ltd. maintains a regional presence across these global markets. No subsidiaries, notable projects, or stock exchange listings have been indicated.
KPL is not part of any active scan today.
This page is a live market overview for Kwality Pharmaceuticals Limite (KPL) on the BSE. As a listed security, Kwality Pharmaceuticals Limite is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for KPL before placing trades on tick2trade.
As of the latest feed, KPL last traded at ₹3,473.55 on BSE, down ₹207.4 (5.63%) from the previous close of ₹3,680.95. Today's session range is ₹3,459.65 – ₹3,729.5, against a 52-week band of ₹1,561 – ₹3,949. Traded volume today stands at 26.86K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for KPL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether KPL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for Kwality Pharmaceuticals Limite before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in KPL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated KPL option chain page linked from this overview.
// similar in healthcare326 total